Mandate

VINGE ADVISES SWEGON

June 09, 2014

Vinge has advised Swegon AB in connection with its acquisition of the Canadian company, Vibro-Acoustics®. Vibro-Acoustics® is a leading producer of acoustic ventilation products and vibration reduction products in North America.

Vibro-Acoustics was established in 1960 and its head office is situated in Toronto. In addition to Toronto, the company also has manufacturing facilities in Nashville and Reno. The company has 167 employees and had a turnover in 2013 of MCAD 28, equivalent to approximately SEK 170 million. Swegon AB is a market-leading producer and supplier of energy efficient ventilation and climate control systems. Swegon AB is a wholly-owned subsidiary of Investment AB Latour.

Swegon was advised by advokat Magnus Pauli.

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024